Bone Metastatic Castration-resistant Prostate Cancer

Explore clinical trials studying Bone Metastatic Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Bone Metastatic Castration-resistant Prostate Cancer trial results

Completed

A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

NCT04521361

Conditions: Bone Metastatic Castration-resistant Prostate Cancer
Locations: Uniklinikum Salzburg - Landeskrankenhaus Salzburg, Austria

ICM - Institut du Cancer de Montpellier - Val d'Aurelle Montpellier, France

HCL - Centre Hospitalier Lyon Sud Pierre-Bénite, France

Institut de Cancerologie Ouest - Saint-Herblain Saint-Herblain, France

View Trial Details

Completed

A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before

NCT04587427

Conditions: Bone Metastatic Castration-resistant Prostate Cancer
Locations: Many Locations Multiple Locations, Denmark

Many Locations Multiple Locations, Germany

Many Locations Multiple Locations, Netherlands

View Trial Details

Completed

Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer

NCT02204943

Conditions: Bone Metastatic Castration-resistant Prostate Cancer
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details